Covered recipient · General Payments record
SAMANTHA NICOLE ROMAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2023–2024
$5,485.53
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,475.00 | 1 |
| Food and Beverage | $1,326.31 | 21 |
| Travel and Lodging | $440.66 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $3,568.40 | 13 |
| GENZYME CORPORATION | $128.49 | 2 |
| Genentech, Inc. | $120.25 | 1 |
| TG THERAPEUTICS, INC. | $105.30 | 1 |
| EMD Serono, Inc. | $83.27 | 1 |
| Genentech USA, Inc. | $80.59 | 1 |
| Alexion Pharmaceuticals, Inc. | $49.56 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.49 | 1 |
| Medtronic, Inc. | $20.66 | 1 |
| Celgene Corporation | $20.66 | 1 |
| Teva Pharmaceuticals USA, Inc. | $18.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $49.56 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094035070 | CMS |
| Amgen Inc. | $25.52 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116065780 | CMS |
| Amgen Inc. | $110.00 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116065787 | CMS |
| Amgen Inc. | $150.00 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116065823 | CMS |
| Amgen Inc. | $334.52 | 04/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116065829 | CMS |
| Amgen Inc. | $50.00 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116065836 | CMS |
| Amgen Inc. | $70.00 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116065843 | CMS |
| Amgen Inc. | $106.14 | 04/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116065849 | CMS |
| Amgen Inc. | $2,475.00 | 04/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116065856 | CMS |
| Amgen Inc. | $111.74 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116065815 | CMS |
| Amgen Inc. | $3.03 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116065793 | CMS |
| Amgen Inc. | $6.64 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116065801 | CMS |
| Amgen Inc. | $116.59 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116065807 | CMS |
| Amgen Inc. | $9.22 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116065863 | CMS |
| Celgene Corporation | $20.66 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101114422 | CMS |
| EMD Serono, Inc. | $83.27 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120244965 | CMS |
| Genentech USA, Inc. | $80.59 | 04/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133105295 | CMS |
| Genentech, Inc. | $120.25 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133105291 | CMS |
| GENZYME CORPORATION | $99.47 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139804046 | CMS |
| GENZYME CORPORATION | $29.02 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139804072 | CMS |
| Medtronic, Inc. | $20.66 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119421999 | CMS |
| Novartis Pharmaceuticals Corporation | $46.49 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087301837 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.30 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151609250 | CMS |
| TG Therapeutics, Inc. | $105.30 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136875134 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.